Author

David Gurwitz

Tel Aviv UniversityORCID 0000-0002-9363-1869Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2

Frequent Co-Authors

Hana Klin· 2 shared Irena VoinskyiD· 2 shared Alessio SquassinaiD· 1 shared Elad ShapiraiD· 1 shared Hadas VolkoviD· 1 shared Meitar GradiD· 1 shared Noam ShomroniD· 1 shared Rani Shlayem· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Hana Klin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintOct 24, 2026

RNA-sequencing of butyrate-treated human lymphoblastoid cell lines shows dysregulated genes of multiple disease-related pathways

Hadas Volkov, Tehila Cohen, Rani Shlayem…·David Gurwitz

This study uses RNA-seq to analyze the transcriptomic effects of butyrate on human lymphoblastoid cell lines, identifying dysregulated genes in multiple disease-related pathways.

DOI 10.64898/2026.10.21.760620

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsDrug Development ResearchPeer-reviewedJul 9, 2025

Reduced taurine transporter expression in lymphoblastoid cell lines from Alzheimer's disease patients compared with age-matched controls: Therapeutic implications?

Yuval Gavriel, Irena Voinsky, Hana Klin…·David Gurwitz

The paper measures SLC6A6 mRNA expression in lymphoblastoid cell lines from Alzheimer's disease patients and finds it is 2.8-fold lower than in age-matched controls, suggesting a potential role for taurine in AD pathogenesis.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky